ANGELONI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.824
EU - Europa 451
AS - Asia 128
AF - Africa 39
SA - Sud America 10
Totale 2.452
Nazione #
US - Stati Uniti d'America 1.794
IT - Italia 135
DE - Germania 93
IN - India 75
SE - Svezia 70
UA - Ucraina 56
CN - Cina 46
FI - Finlandia 43
BJ - Benin 34
GB - Regno Unito 23
BZ - Belize 20
AR - Argentina 9
BG - Bulgaria 8
IE - Irlanda 7
BE - Belgio 6
CA - Canada 6
RU - Federazione Russa 5
MX - Messico 4
TG - Togo 4
FR - Francia 3
SG - Singapore 3
CH - Svizzera 2
CL - Cile 1
JO - Giordania 1
KR - Corea 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.452
Città #
Fairfield 268
Ashburn 127
Chandler 125
Woodbridge 119
Houston 117
Wilmington 101
Seattle 95
Cambridge 86
Dearborn 58
Ann Arbor 57
San Paolo di Civitate 50
Fremont 47
Princeton 44
Plano 40
San Jose 37
Fasano 34
Frankfurt am Main 34
Lawrence 29
Jacksonville 26
Boston 22
Bremen 22
Rome 21
Belize City 20
San Diego 20
Beijing 19
New York 19
Dallas 16
Millbury 16
San Mateo 16
Southend 14
Saint Louis 11
Andover 10
Falls Church 9
Federal 9
Norwalk 9
Atlanta 8
Des Moines 8
Sofia 8
Dublin 7
Milan 7
Boardman 6
Brussels 6
Cagliari 6
Columbus 6
Toronto 5
Chicago 4
Jinan 4
Lomé 4
Nanchang 4
Deiva Marina 3
Helsinki 3
London 3
Auburn Hills 2
Bern 2
Guangzhou 2
Hefei 2
Los Angeles 2
Mexico City 2
Nanjing 2
Torre del Greco 2
Washington 2
Xian 2
Zelo Buon Persico 2
Bologna 1
Carol Stream 1
Changsha 1
Chengdu 1
Chongqing 1
Civitavecchia 1
Fuzhou 1
Harbin 1
Hounslow 1
Indiana 1
Istanbul 1
Kyiv 1
Miami 1
Muizenberg 1
Mumbai 1
Ottawa 1
Redwood City 1
Riva 1
San Francisco 1
Segrate 1
Shaoxing 1
Shenyang 1
Taiyuan 1
Trumbull 1
Wenzhou 1
Totale 1.886
Nome #
Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: Time to update the guidelines? 107
Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial 101
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study 100
Can an incomplete stent expansion modulate the effects of TIPS? 88
Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis 87
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents 78
Progression of low risk esophageal varices in cirrhotic patients 76
Is hyperammonemia really the true cause of altered neuropsychology, brain MR spectroscopy and magnetization transfer after an oral amino acid load in cirrhosis? 76
Endoscopic screening for esophageal varices in cirrhotic patients 75
Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results 75
Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis 74
Natural history of low risk esophageal varices in cirrhotic patients 73
PTFE-covered stent-grafts for tips procedure: One-year patency and clinical results 73
A comparison of cell blood analyzer and manual hemacytometer for polymorphonuclear cell count in the ascttic fluid in cirrhotic patients with and without spontaneous bacterial peritonitis 71
Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. 71
Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis 68
Bone density and nutritional assessment in cirrhotic patients 68
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS): PTFE-covered stent-grafts versus bare stents 67
Prevention of hepatic encephalopathy after porto-systemic shunt 66
Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein 65
Factors predicting the presence of esophageal varices in compensated cirrhotic patients 64
The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension 63
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: still a major problem. 60
Incidence and progression of portal hypertensive gastropathy in patients with liver cirrhosis 58
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts 57
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study 56
Incidence and natural history of small esophageal varices in cirrhotic patients 55
Natural history of the progression of liver disease in cirrhotic patients 55
Intractable hepatic encephalopathy after TIPS with PTFE-covered stent-graft. 55
PTFE-covered stent-grafts for TIPS procedure: One-year patency and clinical results 53
Estrado de nutrition, composicion corporal y metabolismo energetico en pacientes con cirrosis epatica 51
High prevalence of spontaneous porto-systemic shunts in cirrhotic patients with recurrent hepatic encephalopathy: A case control study 49
Hepatic encephalopathy is more frequent and severe after transjugular intrahepatic portosystemic shunt (TIPS) with PTFE-covered stent-grafts 46
Effect of transjugular intrahepatic portosystemic shunt (TIPS) on gastric mucosal lesions in cirrhotic patients. 45
Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma 44
Comparison between lactitol, rifaximin and no treatment in the prevention of hepatic encephalopathy after transjugular intrahepatic porto-systemic shunt (TIPS): Results of a randomized controlled trial 41
Encefalopatia epatica post-TIPS con stent ricoperti: incidenza, fattori di rischio e confronto tra stent di differente diametro 37
Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in cirrhotic patients: Comparison of emergency and elective interventions 31
PERIPHERAL AND SPLANCHNIC INDOLE AND OXINDOLE LEVELS IN CIRRHOTIC PATIENTS: RELATIONSHIP TO HEPATIC ENCEPHALOPATHY 29
Questioned issues in clinical nutrition: the cirrhotic patient before and after orthotopic liver transplantation 27
Totale 2.535
Categoria #
all - tutte 5.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019275 0 0 0 0 0 0 0 2 6 57 119 91
2019/2020813 94 47 10 26 62 283 87 73 71 28 20 12
2020/2021176 15 23 6 19 0 3 3 21 14 30 8 34
2021/2022453 1 23 44 11 62 9 9 41 68 28 70 87
2022/2023505 77 105 56 97 32 53 5 22 41 8 6 3
2023/2024119 10 31 5 20 12 32 0 9 0 0 0 0
Totale 2.535